Join Our Talk at PharmaLab 2026: ML vs. AI-Driven Real-Time Microbiological Monitoring

PharmaLab 2026, Darmstadt: talk by Dr Anne-Grit Klees (Merck) and Dr Svetlana Kiseleva (Plair) on ML vs. AI-driven real-time microbiological monitoring, 24 November 2026, 16:00–16:30, with the Rapid-C+ biofluorescent particle counter
24 November 2026 16:00–16:30 Darmstadt, Germany Session: Artificial Intelligence in Laboratories

“AI” is now on many environmental monitoring instruments. But what does it actually mean for your equipment qualification and validation?

In the Artificial Intelligence in Laboratories session at PharmaLab 2026, Merck and Plair will present:

ML vs. AI-Driven Real-Time Microbiological Monitoring: Impact on Equipment Qualification and Validation in the Pharmaceutical Industry

What you’ll take away

ML and AI in modern methods

How modern microbiological methods use machine learning and AI for environmental monitoring

Locked ML vs. adaptive AI

The difference between a static, locked ML model and an adaptive AI approach in biofluorescent particle counters (BFPCs), and why it matters under GMP

Controlled algorithm changes

When a new or improved algorithm is needed, and how to implement it without uncontrolled changes after qualification

Qualification and validation impact

What an algorithm update means for qualification and primary validation, illustrated with a real BFPC and its validation data

If you work in QA, QC microbiology or validation and are evaluating real-time viable particle counting, come and join the discussion.

Awards


Awards received by Plair SA

Address


Route de Saint-Julien 275
1258 Perly
Switzerland

Contact


info@plair.ch
+41 (22) 552-3830